03 Profile
Vital Signsby Bridgehead
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Rare diseases
Bushra Tbakhi: no photograph is held, so the academic plate is shown instead.
Academic
Bushra Tbakhi
University of Cincinnati, Ohio; lead researcher on the second EoE study
1
Nov 2026to date
1
press citation on 1 topic since 12 Nov 2026 · last quoted 12 Nov 2026
02 Quoted on · 1 of 29 topics
Bushra Tbakhi: key facts
- Kind of voice
- Academic
- Role
- University of Cincinnati, Ohio; lead researcher on the second EoE study
- Quoted on
- Rare diseases
- Tracked press citations
- 1
- Most recently quoted
- 12 Nov 2026
04 The signal · where Bushra Tbakhi sits on rare diseases
Ranked 58= of 100 voices quoted in the press on rare diseases, level with 42 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1Giles LomaxSector leaderChief Executive Officer, Spinal Muscular Atrophy UK (SMA UK)9
- 2=Dr Harrison CarterAcademicDirector of Screening at NHS England8
- 2=Anastasia ZekeridouAcademicNeurologist and researcher at Mayo Clinic, Rochester8
- 58=Pamela HealySector leaderChief Executive of the British Liver Trust1
- 58=Dr Joe AbbottAcademicophthalmologist1
- 58=Bushra TbakhiAcademicUniversity of Cincinnati, Ohio; lead researcher on the second EoE study1
- 58=Talal NsouliAcademicGeorgetown University, Washington DC; lead researcher on the first EoE study1
- 58=Eleanor ThomasAcademicMD, PhD, assistant professor of neurology at Emory University School of Medicine and co-principal investigator of the study1
Showing the leaders and the ranks around 58=, of 100 voices · See every voice on the topic →
05 On the record · press
What Bushra Tbakhi has said
By outlet · linked articles
- newscientist.com1
Where Bushra Tbakhi has been quoted
- 01A little-known immune condition is being mistaken for food allergies | New Scientistnewscientist.com · 12 Nov 2026
Verbatim
“Associated allergic conditions may help identify patients at high risk for eosinophilic oesophagitis.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
- Coventry tot's heartbreaking health battle after 'extremely rare' diagnosiscoventrytelegraph.net
- Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdlereuters.com
- 'Immoral lottery' - Mum's plea after losing daughter to rare diseasethewestmorlandgazette.co.uk
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 12 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.